Simultaneous monitoring of multiple urinary cytokines may predict renal and patient outcome in ischemic AKI

Renal Failure

Volumn 32, Issue 6, 2010, Pages 699-708

  Kwon, Osun ^a   Ahn, Kwangmi ^a   Zhang, Binzhi ^a   Lockwood, Tammy ^a   Dhamija, Rajiv ^a   Anderson, Darryl ^a   Saqib, Najum ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Acute kidney injury; Acute renal failure; Biomarkers; Cytokines; Ischemic acute renal failure; Urine

Indexed keywords

CREATININE; CYTOKINE; EPIDERMAL GROWTH FACTOR; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; TRANSFORMING GROWTH FACTOR ALPHA; VASCULOTROPIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE URINE LEVEL; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; IMMUNOFLUORESCENCE TEST; KIDNEY FUNCTION; KIDNEY INJURY; KIDNEY ISCHEMIA; MALE; MORTALITY; OUTCOME ASSESSMENT; PREDICTION; PREDICTIVE VALIDITY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; URINALYSIS; URINE LEVEL;

ACUTE KIDNEY INJURY; AGED; CYTOKINES; FEMALE; HUMANS; ISCHEMIA; KIDNEY; MALE; MIDDLE AGED; PILOT PROJECTS; PREDICTIVE VALUE OF TESTS; TIME FACTORS;

EID: 77953567863     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2010.486496     Document Type: Article

References (41)

1. Chertow GM, Christiansen CL, Cleary PD, Munro C, Lazarus JM. Prognostic stratification in critically ill patients with acute renal failure requiring dialysis. Arch Intern Med. 1995;155: 1505-1511.
2. Levy EM, Viscoli CM, Horwitz RI. The effect of acute renal failure on mortality. A cohort analysis. JAMA. 1996;275: 1489-1494.
3. Thadhani R, Pascual M, Bonventre JV. Acute renal failure. N Engl J Med. 1996;334:1448-1460.
4. Liano F, Pascual J. Outcomes in acute renal failure. Semin Nephrol. 1998;18:541-550.
5. Kelly KJ, Molitoris BA. Acute renal failure in the new millennium: Time to consider combination therapy. Semin Nephrol. 2000;20:4-19.
6. Clermont G, Acker CG, Angus DC, Sirio CA, Pinsky MR, Johnson JP. Renal failure in the ICU. Comparison of the impact of acute renal failure and end-stage renal disease on ICU outcomes. Kidney Int. 2002;62:986-996.
7. Uchino S, Kellum JA, Bellomo R, et al.. Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators. Acute renal failure in critically ill patients: A multinational, multicenter study. JAMA. 2005;294:813-818.
8. Xue JL, Daniels F, Star RA, et al.. Incidence and mortality of acute renal failure in Medicare beneficiaries, 1992 to 2001. J Am Soc Nephrol. 2006;17:1135-1142.
9. Ali T, Khan I, Simpson W, et al.. Incidence and outcomes in acute kidney injury: A comprehensive population-based study. J Am Soc Nephrol. 2007;18:1292-1298.
10. Himmelfarb J, Ikizler TA. Acute kidney injury: Changing lexicography, definitions, and epidemiology. Kidney Int. 2007; 71:971-976.
11. Mehta R, Kellum J, Shah S, et al.. Acute Kidney Injury Network: Report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007;11:R31, DOI: 10.1186/cc5713. (Pubitemid 46604959)
12. Ramesh G, Zhang B, Uematsu S, Akira S, Reeves WB. Endotoxin and cisplatin synergistically induce renal dysfunction and cytokine production in mice. Am J Physiol Renal Physiol. 2007;293:F325-F332. (Pubitemid 47345033)
13. Kwon O, Molitoris BA, Pescovitz M, Kelly KJ. Urinary actin, interleukin-6, and interleukin-8 may predict sustained ARF after ischemic injury in renal allografts. Am J Kidney Dis. 2003; 41:1074-1087.
14. Mishra J, Ma Q, Prada A, et al.. Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol. 2003;14: 2534-2543.
15. Mishra J, Dent C, Tarabishi R, et al.. Neutrophil gelatinaseassociated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet. 2005;365:1231-1238.
16. Parikh CR, Abraham E, Ancukiewicz M, Edelstein CL for the Acute Respiratory Distress Syndrome (ARDS) Network. Urine IL-18 is an early diagnostic marker for acute kidney injury and predicts mortality in the intensive care unit. J Am Soc Nephrol. 2005;16:3046-3052.
17. Parikh CR, Mishra J, Thiessen-Philbrook H, et al.. Urinary IL-18 is an early predictive biomarker of acute kidney injury after cardiac surgery. Kidney Int. 2006;70:199-203.
18. Ichimura T, Hung CC, Yang SA, Stevens JL, Bonventre JV. Kidney injury molecule-1: A tissue and urinary biomarker for nephrotoxicant-induced renal injury. Am J Physiol Renal Physiol. 2004;286:F552-F563.
19. Vaidya VS, Ramirez V, Ichimura T, Bobadilla NA, Bonventre JV. Urinary kidney injury molecule-1: A sensitive quantitative biomarker for early detection of kidney tubular injury. Am J Physiol Renal Physiol. 2006;290:F517-F529.
20. Nguyen MT, Ross G, Harris N, Kathman T, Dent C, Devarajan P. Abstract paper, Novel early biomarkers of acute kidney injury. Renal Week 2006 of the American Society of Nephrology, San Diego, CA, November 14-19, 2006
21. Parikh CR, Jani A, Melnikov VY, Faubel S, Edelstein CL. Urinary interleukin-18 is a marker of human acute tubular necrosis. Am J Kidney Dis. 2004;43:405-414.
22. Liangos O, Perianayagam MC, Vaidya VS, et al.. Urinary N-acetyl-b-(D)-glucosaminidase activity and kidney injury molecule-1 level are associated with adverse outcomes in acute renal failure. J Am Soc Nephrol. 2007;18:904-912.
23. du Cheyron D, Daubin C, Poggioli J, et al.. Urinary measurement of Na+/H+ exchanger isoform 3 (NHE3) protein as new marker of tubule injury in critically ill patients with ARF. Am J Kidney Dis. 2003;42:497-506.
24. Zager RA, Johnson ACM, Lund S, Randolph-Habecker J. Toll-like receptor (TLR4) shedding and depletion: Acute proximal tubular cell responses to hypoxic and toxic injury. Am J Physiol Renal Physiol. 2007;292:F304-F312.
25. Portilla D, Dent C, Sugaya T, et al.. Liver fatty acid-binding protein as a biomarker of acute kidney injury after cardiac surgery. Kidney Int. 2008;73:465-472. (Pubitemid 351186293)
26. Luster AD, Unkeless JC, Ravetch JV. g-Interferon transcriptionally regulates an early-response gene containing homology to platelet proteins. Nature. 1985;315:672-676.
27. Taub DD, Lloyd AR, Conlon K, et al.. Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells. J Exp Med. 1993;177:1809-1814.
28. Tatapudi RR, Muthukumar T, Dadhania D, et al.. Noninvasive detection of renal allograft inflammation by measurements of mRNA for IP-10 and CXCR3 in urine. Kidney Int. 2004; 65:2390-2397.
29. Panzer U, Reinking RR, Steinmetz OM, et al.. CXCR3 and CCR5 positive T-cell recruitment in acute human renal allograft rejection. Transplantation. 2004;78:1341-1350.
30. Matz M, Beyer J, Wunsch D, et al.. Early post-transplant urinary IP-10 expression after kidney transplantation is predictive of short- and long-term graft function. Kidney Int. 2006; 69:1683-1690.
31. Furuichi K, Wada T, Iwata Y, et al.. Interleukin-1-dependent sequential chemokine expression and inflammatory cell infiltration in ischemia-reperfusion injury. Crit Care Med. 2006;34:2447-2455.
32. Furuichi K, Wada T, Iwata Y, et al.. CCR2 signaling contributes to ischemia-reperfusion injury in kidney. J Am Soc Nephrol. 2003;14:2503-2515.
33. Jo SK, Sung SA, Cho WY, Go KJ, Kim HK. Macrophages contribute to the initiation of ischemic acute renal failure in rats. Nephrol Dial Transplant. 2006;21:1231-1239.
34. Ramesh G, Reeves WB. TNF-alpha mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity. J Clin Invest. 2002;110:835-842.
35. Maier S, Emmanuilidis K, Entleutner M, et al.. Massive chemokine transcription in acute renal failure due to polymicrobial sepsis. Shock. 2000;14:187-192.
36. Bocci V. Renal catabolism of interferons, interleukins 1 and 2 and tumor necrosis factor. Contrib Nephrol. 1988;68:53-57.
37. Basile DP. The transforming growth factor beta system in kidney disease and repair: Recent progress and future directions. Curr Opin Nephrol Hypertens. 1999;8:21-30.
38. Schrijvers BF, Flyvbjerg A, de Vriese AS. The role of vascular endothelial growth factor (VEGF) in renal pathophysiology. Kidney Int. 2004;65:2003-2017.
39. Vannay A, Fekete A, Adori C, et al.. Divergence of renal vascular endothelial growth factor mRNA expression and protein level in post-ischemic rat kidneys. Exp Physiol. 2004; 89:435-444.
40. Kitamoto Y, Matsuo K, Tomita K. Different response of urinary excretion of VEGF in patients with chronic and acute renal failure. Kidney Int. 2001;59:385-386.
41. Tsau YK, Sheu JN, Chen CH, Teng RJ, Chen HC. Decreased urinary epidermal growth factor in children with acute renal failure: Epidermal growth factor/creatinine ratio not a reliable parameter for urinary epidermal growth factor excretion. Pediatr Res. 1996;39:20-24.